Fulgent Genetics, Inc. (FLGT)
21.74
+0.92
(+4.42%)
USD |
NASDAQ |
Oct 09, 16:00
21.72
-0.02
(-0.09%)
After-Hours: 20:00
Fulgent Genetics Enterprise Value : 345.11M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 345.11M |
| October 08, 2026 | 319.80M |
| October 07, 2026 | 312.92M |
| October 06, 2026 | 313.20M |
| October 05, 2026 | 364.65M |
| October 02, 2026 | 337.96M |
| October 01, 2026 | 333.01M |
| September 30, 2026 | 352.82M |
| September 29, 2026 | 354.47M |
| September 28, 2026 | 362.17M |
| September 25, 2026 | 357.77M |
| September 24, 2026 | 339.89M |
| September 23, 2026 | 332.18M |
| September 22, 2026 | 342.64M |
| September 21, 2026 | 339.61M |
| September 18, 2026 | 343.74M |
| September 17, 2026 | 348.14M |
| September 16, 2026 | 342.09M |
| September 15, 2026 | 332.46M |
| September 14, 2026 | 315.12M |
| September 11, 2026 | 309.62M |
| September 10, 2026 | 300.54M |
| September 09, 2026 | 293.11M |
| September 08, 2026 | 302.74M |
| September 04, 2026 | 289.81M |
| Date | Value |
|---|---|
| September 03, 2026 | 287.61M |
| September 02, 2026 | 298.34M |
| September 01, 2026 | 285.96M |
| August 31, 2026 | 279.90M |
| August 28, 2026 | 286.51M |
| August 27, 2026 | 295.86M |
| August 26, 2026 | 292.01M |
| August 25, 2026 | 295.86M |
| August 24, 2026 | 282.10M |
| August 21, 2026 | 294.49M |
| August 20, 2026 | 295.04M |
| August 19, 2026 | 290.08M |
| August 18, 2026 | 257.89M |
| August 17, 2026 | 260.37M |
| August 14, 2026 | 257.62M |
| August 13, 2026 | 260.09M |
| August 12, 2026 | 261.74M |
| August 11, 2026 | 269.72M |
| August 10, 2026 | 271.37M |
| August 07, 2026 | 273.58M |
| August 06, 2026 | 257.34M |
| August 05, 2026 | 256.79M |
| August 04, 2026 | 257.34M |
| August 03, 2026 | 231.48M |
| July 31, 2026 | 202.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 31.55B |
| Labcorp Holdings, Inc. | 31.89B |
| OPKO Health, Inc. | 1.127B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.394B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.72M |
| Revenue (Quarterly) | 85.39M |
| Total Expenses (Quarterly) | 114.92M |
| EPS Diluted (Quarterly) | -1.054 |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -13.01% |
| Normalized Earnings Yield | -12.42 |